Anti-human-HER3 antibodies and uses thereof
US11001634B2 · kind B2 · utility
0Cited by
0References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 2, 2016 |
| Grant date | May 11, 2021 |
| Priority date | — |
| Expiry date | May 2, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to a neuregulin non competitive allosteric anti-human-HER3 antibody having a human constant region; and less than 65% of the glycan structures carried by the glycosylation site of the antibody comprises a fucose molecule. The antibody is characterized by its variable sequences.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.